Literature DB >> 23476091

Evaluation, in three provinces, of the introduction and impact of China's National Essential Medicines Scheme.

Yang Li1, Cui Ying, Guo Sufang, Philippa Brant, Li Bin, David Hipgrave.   

Abstract

OBJECTIVE: To evaluate implementation of the National Essential Medicines Scheme (NEMS) in rural China.
METHODS: Two rural counties/districts in each of three provinces where NEMS had been implemented were surveyed. Information was collected from NEMS staff at the province, county/district, township and village levels; patients with chronic disease were also interviewed. Service provision, finances, prescriptions, inpatient records and the expenditures of patients with certain diagnoses were investigated in township hospitals and village clinics. The results were compared with the corresponding data recorded before NEMS was introduced.
FINDINGS: Following the introduction of NEMS, drug procurement in each study location was systematized. Total drug costs declined. This, and improved prescribing, reduced the costs of outpatient and inpatient care and led, apparently, to increased uptake of health services. However, the prices of some drugs had increased and the availability of others had declined. The compensation of health-care providers for NEMS-related reductions in their incomes had been largely ineffective. As a result of the introduction of NEMS, health facilities relied more on public financing. Many health-care providers complained about higher workloads and lower incomes.
CONCLUSION: Although it was well conceived, the introduction of NEMS into China's decentralized, fee-for-service system of health care has not been straightforward. It has highlighted the problems associated with attempts to modernize health care and health financing for patients' benefit. Sustainable mechanisms to compensate health-care providers for lost income are needed to ensure that NEMS is a success.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23476091      PMCID: PMC3590616          DOI: 10.2471/BLT.11.097998

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  19 in total

1.  Prescribing practices of rural primary health care physicians in Uzbekistan.

Authors:  Melinda Pavin; Talgat Nurgozhin; Grace Hafner; Farruh Yusufy; Richard Laing
Journal:  Trop Med Int Health       Date:  2003-02       Impact factor: 2.622

Review 2.  Pharmaceutical supply chain in China: current issues and implications for health system reform.

Authors:  Xuan Yu; Cheng Li; Yuhua Shi; Min Yu
Journal:  Health Policy       Date:  2010-03-21       Impact factor: 2.980

3.  Privatization and its discontents--the evolving Chinese health care system.

Authors:  David Blumenthal; William Hsiao
Journal:  N Engl J Med       Date:  2005-09-15       Impact factor: 91.245

4.  Reform of how health care is paid for in China: challenges and opportunities.

Authors:  Shanlian Hu; Shenglan Tang; Yuanli Liu; Yuxin Zhao; Maria-Luisa Escobar; David de Ferranti
Journal:  Lancet       Date:  2008-10-17       Impact factor: 79.321

5.  Antibiotic prescribing patterns in village health clinics across 10 provinces of Western China.

Authors:  Lifang Dong; Hong Yan; Duolao Wang
Journal:  J Antimicrob Chemother       Date:  2008-04-09       Impact factor: 5.790

Review 6.  China's health system and its reform: a review of recent studies.

Authors:  Adam Wagstaff; Winnie Yip; Magnus Lindelow; William C Hsiao
Journal:  Health Econ       Date:  2009-07       Impact factor: 3.046

7.  Issues in drug pricing, reimbursement, and access in China with references to other Asia-Pacific region.

Authors:  Yingyao Chen; Stuart O Schweitzer
Journal:  Value Health       Date:  2008-03       Impact factor: 5.725

8.  Essential drugs policy in three rural counties in China: what does a complexity lens add?

Authors:  Yue Xiao; Kun Zhao; David M Bishai; David H Peters
Journal:  Soc Sci Med       Date:  2012-10-05       Impact factor: 4.634

9.  Prescribing behaviour of village doctors under China's New Cooperative Medical Scheme.

Authors:  Xiaoyun Sun; Sukhan Jackson; Gordon A Carmichael; Adrian C Sleigh
Journal:  Soc Sci Med       Date:  2009-04-01       Impact factor: 4.634

10.  Tackling the challenges to health equity in China.

Authors:  Shenglan Tang; Qingyue Meng; Lincoln Chen; Henk Bekedam; Tim Evans; Margaret Whitehead
Journal:  Lancet       Date:  2008-10-17       Impact factor: 79.321

View more
  36 in total

1.  The evolution of Reference Drug Lists and Clinical Practice Guidelines in the public health system of a middle-income country.

Authors:  Israel Rico-Alba; Albert Figueras
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

2.  Child health security in China: a survey of child health insurance coverage in diverse areas of the country.

Authors:  Juyang Xiong; David Hipgrave; Karoline Myklebust; Sufang Guo; Robert W Scherpbier; Xuetao Tong; Lan Yao; Andrew E Moran
Journal:  Soc Sci Med       Date:  2013-08-24       Impact factor: 4.634

3.  Health system strengthening and hypertension awareness, treatment and control: data from the China Health and Retirement Longitudinal Study.

Authors:  Xing Lin Feng; Mingfan Pang; John Beard
Journal:  Bull World Health Organ       Date:  2013-09-10       Impact factor: 9.408

4.  A cross-sectional analysis of prescription and stakeholder surveys following essential medicine reform in Guangdong Province, China.

Authors:  Wen-yuan Zhang; Ying-ran Li; Yun-jing Li; Xue-qin Li; Wei-guo Zhao; Rong-zhi Lu
Journal:  BMC Health Serv Res       Date:  2015-03-13       Impact factor: 2.655

5.  Evaluation of the implementation outcomes of the Essential Medicines System in Anhui county-level public hospitals: a before-and-after study.

Authors:  Shuman Xu; Cheng Bian; Heng Wang; Niannian Li; Jingya Wu; Peng Li; Hua Lu
Journal:  BMC Health Serv Res       Date:  2015-09-22       Impact factor: 2.655

6.  How China's new health reform influences village doctors' income structure: evidence from a qualitative study in six counties in China.

Authors:  Shengfa Zhang; Weijun Zhang; Huixuan Zhou; Huiwen Xu; Zhiyong Qu; Mengqi Guo; Fugang Wang; You Zhong; Linni Gu; Xiaoyun Liang; Zhihong Sa; Xiaohua Wang; Donghua Tian
Journal:  Hum Resour Health       Date:  2015-05-05

7.  The reform of the essential medicines system in China: a comprehensive approach to universal coverage.

Authors:  Sarah L Barber; Baobin Huang; Budiono Santoso; Richard Laing; Valerie Paris; Chunfu Wu
Journal:  J Glob Health       Date:  2013-06       Impact factor: 4.413

8.  The effect of the National Essential Medicines Policy on health expenditures and service delivery in Chinese township health centres: evidence from a longitudinal study.

Authors:  Xin Zhang; Qunhong Wu; Guoxiang Liu; Ye Li; Lijun Gao; Bin Guo; Wenqi Fu; Yanhua Hao; Yu Cui; Weidong Huang; Peter C Coyte
Journal:  BMJ Open       Date:  2014-12-22       Impact factor: 2.692

9.  The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study.

Authors:  Dongfeng Gu; Jiang He; Pamela G Coxson; Petra W Rasmussen; Chen Huang; Anusorn Thanataveerat; Keane Y Tzong; Juyang Xiong; Miao Wang; Dong Zhao; Lee Goldman; Andrew E Moran
Journal:  PLoS Med       Date:  2015-08-04       Impact factor: 11.069

10.  Urban-rural inequality regarding drug prescriptions in primary care facilities - a pre-post comparison of the National Essential Medicines Scheme of China.

Authors:  Qiang Yao; Chaojie Liu; J Adamm Ferrier; Zhiyong Liu; Ju Sun
Journal:  Int J Equity Health       Date:  2015-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.